US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapix Biosciences Ltd.

0.3170

0.0000

Volume:- -

Turnover:- -

Market Cap:1.81M

PE:-0.11

High:0.3170

Open:0.3170

Low:0.3170

Close:0.3170

Loading ...

Overview Company News Filings

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers

Correspondence

CORRESP [Cover] - Correspondence

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Correspondence

CORRESP [Cover] - Correspondence

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Public Prospectus

Registration statement for certain foreign private issuers

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TRPX/filings?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRPX\",,,,,undefined,":{"symbol":"TRPX","market":"US","secType":"STK","nameCN":"Therapix Biosciences Ltd.","latestPrice":0.317,"timestamp":1593633600000,"preClose":0.317,"halted":4,"volume":0,"delay":0,"floatShares":5578438,"shares":5719700,"eps":-2.797749,"marketStatus":"Delisted","change":0,"latestTime":"07-01 16:00:00 EDT","open":0.317,"high":0.317,"low":0.317,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.797749,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747900800000},"marketStatusCode":0,"adr":0,"adrRate":40,"listingDate":1490155200000,"exchange":"NASDAQ","adjPreClose":0.317,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRPX\",,,,,undefined,":{"symbol":"TRPX","floatShares":5578438,"roa":"-89.87%","roe":"-9843.96%","lyrEps":-170.15344,"shares":5719700,"dividePrice":0,"high":0.317,"amplitude":0,"preClose":0.317,"low":0.317,"week52Low":0.2522,"pbRate":"129.51","week52High":4.69,"institutionHeld":0,"latestPrice":0.317,"eps":-2.797749,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.797749,"open":0.317},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"TRPX\",pageSize:20,pageCount:2,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"9799504","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020014454-TRPX","pdf_url":null,"pub_time":1591632000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","symbol":"TRPX","title":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020014454/0001213900-20-014454-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020014454/ea122838-13da1pure_therapix.htm","primary":true,"translateUrl":null,"linkName":"ea122838-13da1pure_therapix.htm","type":"SC 13D/A","id":"NTFILE6bMbdAiaaWNEGFza","market":"us","size":90442}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2020-06-09 00:00","pubTimestamp":1591632000,"title_zh":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9782140","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020013951-TRPX","pdf_url":null,"pub_time":1591027200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D  - General statement of acquisition of beneficial ownership","symbol":"TRPX","title":"SC 13D  - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020013951/0001213900-20-013951-index.htm","us_notice_code":"Form SC 13D","us_title_en":"SC 13D  - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020013951/ea122591-13dpure_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"ea122591-13dpure_therapixbio.htm","type":"SC 13D","id":"NTFILECu2aGAb8tbkRa7my","market":"us","size":196020},{"description":"DEMAND LETTER TO CONVENE A SPECIAL GENERAL MEETING OF THE SHAREHOLDERS OF THE RE","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020013951/ea122591ex1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea122591ex1_therapixbio.htm","type":"EX-99.1","id":"NTFILEChqpQA8qTVEkGCoi","market":"us","size":16199},{"description":"POSITION STATEMENT IN CONNECTION WITH THE DEMAND LETTER TO CONVENE A SPECIAL GEN","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020013951/ea122591ex2_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea122591ex2_therapixbio.htm","type":"EX-99.2","id":"NTFILEUNfvXz5Uq2AnFQST","market":"us","size":18110},{"description":"JOINT FILING AGREEMENT BY AND AMONG L.I.A. PURE CAPITAL LTD. AND KFIR SILBERMAN,","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020013951/ea122591ex3_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea122591ex3_therapixbio.htm","type":"EX-99.3","id":"NTFILE49Kh32b5SrxDmPDe","market":"us","size":4384}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2020-06-02 00:00","pubTimestamp":1591027200,"title_zh":"SC 13D  - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9665202","market":"us","labels":[],"media":"sec.gov","original_id":"AN89542120000317-TRPX","pdf_url":null,"pub_time":1588176000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Statement of acquisition of beneficial ownership by individuals","symbol":"TRPX","title":"Statement of acquisition of beneficial ownership by individuals","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000089542120000317/0000895421-20-000317-index.htm","us_notice_code":"Form SC 13G","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"MS INITIAL","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/895421/000089542120000317/TherapixBiosciences.txt","primary":true,"translateUrl":null,"linkName":"TherapixBiosciences.txt","type":"SC 13G","id":"NTFILE3oVngNz4ZPjv2uyV","market":"us","size":15649}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2020-04-30 00:00","pubTimestamp":1588176000,"title_zh":"Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9394720","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020008164-TRPX","pdf_url":null,"pub_time":1585584000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Registration statement for certain foreign private issuers","symbol":"TRPX","title":"[Amend] Registration statement for certain foreign private issuers","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020008164/0001213900-20-008164-index.htm","us_notice_code":"Form F-1/A","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 4 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020008164/ea120248-f1a4_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"ea120248-f1a4_therapixbio.htm","type":"F-1/A","id":"NTFILE57apeYrSqpBkcELm","market":"us","size":1449356},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020008164/ea120248ex4-7_therapix.htm","primary":false,"translateUrl":null,"linkName":"ea120248ex4-7_therapix.htm","type":"EX-4.7","id":"NTFILE12mWwQHZCBbgTT4H","market":"us","size":246843},{"description":"FORM OF PRE-FUNDED WARRANT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020008164/ea120248ex4-8_therapix.htm","primary":false,"translateUrl":null,"linkName":"ea120248ex4-8_therapix.htm","type":"EX-4.8","id":"NTFILEFz9Vs9HA3dRaEe2o","market":"us","size":95330},{"description":"FORM OF SERIES B WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020008164/ea120248ex4-9_therapix.htm","primary":false,"translateUrl":null,"linkName":"ea120248ex4-9_therapix.htm","type":"EX-4.9","id":"NTFILEExYXberYaLTKZmuD","market":"us","size":123098},{"description":"CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL.","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020008164/ea120248ex23-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"ea120248ex23-1_therapix.htm","type":"EX-23.1","id":"NTFILEMx3DeBqa7Yoif8Tg","market":"us","size":2765},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020008164/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE8Bj896gfQX6RKEZS","market":"us","size":29351}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2020-03-31 00:00","pubTimestamp":1585584000,"title_zh":"Amend] Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9388253","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020007879-TRPX","pdf_url":null,"pub_time":1585497600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Registration statement for certain foreign private issuers","symbol":"TRPX","title":"[Amend] Registration statement for certain foreign private issuers","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/0001213900-20-007879-index.htm","us_notice_code":"Form F-1/A","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 3 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ea120156-f1a3_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"ea120156-f1a3_therapixbio.htm","type":"F-1/A","id":"NTFILEFjm2UgEq6cJyF4gx","market":"us","size":1415545},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ea120156ex4-7_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea120156ex4-7_therapixbio.htm","type":"EX-4.7","id":"NTFILE3ASu33VxhEZG2sdA","market":"us","size":201946},{"description":"FORM OF PRE-FUNDED WARRANT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ea120156ex4-8_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea120156ex4-8_therapixbio.htm","type":"EX-4.8","id":"NTFILE24v2szKJxumZf2W7","market":"us","size":96582},{"description":"FORM OF SERIES B WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ea120156ex4-9_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea120156ex4-9_therapixbio.htm","type":"EX-4.9","id":"NTFILEFfi1G6Vt1Uiw2dSW","market":"us","size":125869},{"description":"OPINION OF ZYSMAN, AHARONI, GAYER AND SULLIVAN & WORCESTER LLP.","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ea120156ex5-2_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea120156ex5-2_therapixbio.htm","type":"EX-5.2","id":"NTFILE3paTs1HifYHTXhTd","market":"us","size":14431},{"description":"CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL.","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ea120156ex23-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea120156ex23-1_therapixbio.htm","type":"EX-23.1","id":"NTFILECWjggSst9VXrm8th","market":"us","size":3924},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE2JY7GjsrcJEhKRxB","market":"us","size":29351},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ex5-2_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILE7YLoNcajgCQCDyNn","market":"us","size":11737},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/ex5-2_002.jpg","primary":false,"translateUrl":null,"linkName":"ex5-2_002.jpg","type":"GRAPHIC","id":"NTFILE9WUoLdY2rA1Grf1j","market":"us","size":6530},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007879/image_002.jpg","primary":false,"translateUrl":null,"linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILEBx3peSaVtHTZ8gGx","market":"us","size":2276}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2020-03-30 00:00","pubTimestamp":1585497600,"title_zh":"Amend] Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9643223","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020007609-TRPX","pdf_url":null,"pub_time":1585238400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"TRPX","title":"CORRESP [Cover] - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007609/0001213900-20-007609-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007609/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILE7RM8qJtXpf6c57wF","market":"us","size":4897}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2020-03-27 00:00","pubTimestamp":1585238400,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"CORRESP [Cover] - Correspondence","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"9230876","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020007401-TRPX","pdf_url":null,"pub_time":1585152000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"F-1/A [Amend]  - Registration statement for certain foreign private issuers","symbol":"TRPX","title":"F-1/A [Amend]  - Registration statement for certain foreign private issuers","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007401/0001213900-20-007401-index.htm","us_notice_code":"Form F-1/A","us_title_en":"F-1/A [Amend]  - Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2020-03-26 00:00","pubTimestamp":1585152000,"title_zh":"F-1/A [Amend]  - Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9219818","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020007166-TRPX","pdf_url":null,"pub_time":1584979200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"6-K  - Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"6-K  - Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/0001213900-20-007166-index.htm","us_notice_code":"Form 6-K","us_title_en":"6-K  - Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"THERAPIX BIOSCIENCES LTD. SIGNS SECURITIES PURCHASE AGREEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/ea119823ex99-1_therapix.htm","primary":true,"translateUrl":null,"linkName":"ea119823ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILE2QxKLi89HbYno7wb","market":"us","size":7382},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/ea119823-6k_therapixbios.htm","primary":false,"translateUrl":null,"linkName":"ea119823-6k_therapixbios.htm","type":"6-K","id":"NTFILE5YKCpmEcsQKxGZgy","market":"us","size":28377},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/ea119823ex99-2_therapix.htm","primary":false,"translateUrl":null,"linkName":"ea119823ex99-2_therapix.htm","type":"EX-99.2","id":"NTFILE5Zvb1uJMYt26Tv2m","market":"us","size":80208},{"description":"FORM OF CONVERTIBLE PROMISSORY NOTE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/ea119823ex99-3_therapix.htm","primary":false,"translateUrl":null,"linkName":"ea119823ex99-3_therapix.htm","type":"EX-99.3","id":"NTFILEETb49SFe4ae5YJCH","market":"us","size":48227},{"description":"FORM OF WARRANT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/ea119823ex99-4_therapix.htm","primary":false,"translateUrl":null,"linkName":"ea119823ex99-4_therapix.htm","type":"EX-99.4","id":"NTFILEEDqSZikkNCCoWaGZ","market":"us","size":62754},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE7wPb6Wn2nn6DGm3F","market":"us","size":11678}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2020-03-24 00:00","pubTimestamp":1584979200,"title_zh":"6-K  - Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9643224","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020006837-TRPX","pdf_url":null,"pub_time":1584547200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"TRPX","title":"CORRESP [Cover] - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006837/0001213900-20-006837-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006837/filename1.htm","primary":true,"translateUrl":null,"linkName":"filename1.htm","type":"CORRESP","id":"NTFILE4sqddTsVm3TpH8U1","market":"us","size":10382}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2020-03-19 00:00","pubTimestamp":1584547200,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"CORRESP [Cover] - Correspondence","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9203972","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020006836-TRPX","pdf_url":null,"pub_time":1584547200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"[Amend] Registration statement for certain foreign private issuers","symbol":"TRPX","title":"[Amend] Registration statement for certain foreign private issuers","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/0001213900-20-006836-index.htm","us_notice_code":"Form F-1/A","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM F-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/ea119642-f1a1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"ea119642-f1a1_therapixbio.htm","type":"F-1/A","id":"NTFILE87bzN2xLwbbsmbgG","market":"us","size":1526059},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/ea119642ex4-7_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea119642ex4-7_therapixbio.htm","type":"EX-4.7","id":"NTFILEAYwWewNH9aBQoJNf","market":"us","size":193493},{"description":"FORM OF PRE-FUNDED WARRANT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/ea119642ex4-8_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea119642ex4-8_therapixbio.htm","type":"EX-4.8","id":"NTFILECwuBMdnp2peBqR8S","market":"us","size":94659},{"description":"FORM OF SERIES B WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/ea119642ex4-9_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea119642ex4-9_therapixbio.htm","type":"EX-4.9","id":"NTFILE4nh6kbUrqE7B76fj","market":"us","size":123938},{"description":"CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/ea119642ex23-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea119642ex23-1_therapixbio.htm","type":"EX-23.1","id":"NTFILECfbQEauumorDDp9p","market":"us","size":4458},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE8HFDDrcBN7xvLpG6","market":"us","size":29197},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020006836/image_002.jpg","primary":false,"translateUrl":null,"linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE9PyGhCzGDzjo1s9C","market":"us","size":2276}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2020-03-19 00:00","pubTimestamp":1584547200,"title_zh":"Amend] Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9153290","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020005242-TRPX","pdf_url":null,"pub_time":1583164800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020005242/0001213900-20-005242-index.htm","us_notice_code":"Form 6-K","us_title_en":null,"is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON FEBRUARY 27, 2020, TITLED \"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020005242/ea119178ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"ea119178ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILE8DWaoraQgKMzSPV3","market":"us","size":7656},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020005242/ea119178-6k_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ea119178-6k_therapixbio.htm","type":"6-K","id":"NTFILEH3gLK2nfPufxVstN","market":"us","size":11933},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020005242/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEAQZNcdSuhZBXE9LG","market":"us","size":28726}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2020-03-03 00:00","pubTimestamp":1583164800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9065340","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020002845-TRPX","pdf_url":null,"pub_time":1581004800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002845/0001213900-20-002845-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002845/f6k020820_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k020820_therapixbio.htm","type":"6-K","id":"NTFILEJ5nsW5YMB1jhsXNc","market":"us","size":11393},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON FEBRUARY 6, 2020, TITLED \"N","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002845/f6k020820ex99-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k020820ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILE7ZaK1c67ifTS9tLG","market":"us","size":5784},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002845/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEEvWCDMZzr5DFGa1S","market":"us","size":26348}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2020-02-07 00:00","pubTimestamp":1581004800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9038758","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020002182-TRPX","pdf_url":null,"pub_time":1580400000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Registration statement for certain foreign private issuers","symbol":"TRPX","title":"Registration statement for certain foreign private issuers","titleType":"Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002182/0001213900-20-002182-index.htm","us_notice_code":"Form F-1","us_title_en":"Registration statement for certain foreign private issuers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002182/ff12020_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"ff12020_therapixbio.htm","type":"F-1","id":"NTFILEC4CMatu9NkMswzNd","market":"us","size":423335},{"description":"CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002182/ff12020ex23-1_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"ff12020ex23-1_therapixbio.htm","type":"EX-23.1","id":"NTFILEGbiWHzajGB7n1gTa","market":"us","size":3252},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020002182/image_01.jpg","primary":false,"translateUrl":null,"linkName":"image_01.jpg","type":"GRAPHIC","id":"NTFILEC5DnkwfAd8cTYV2b","market":"us","size":16331}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Public Prospectus","pubTime":"2020-01-31 00:00","pubTimestamp":1580400000,"title_zh":"Registration statement for certain foreign private issuers","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9019246","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020001551-TRPX","pdf_url":null,"pub_time":1579622400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020001551/0001213900-20-001551-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 6-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020001551/f6k012220_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k012220_therapixbio.htm","type":"6-K","id":"NTFILE33HdhY86XWPk7pVc","market":"us","size":11187}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2020-01-22 00:00","pubTimestamp":1579622400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8977362","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000517-TRPX","pdf_url":null,"pub_time":1578412800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020000517/0001213900-20-000517-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020000517/f6k010820_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k010820_therapixbio.htm","type":"6-K","id":"NTFILEBWJV39RZNYpRNiS8","market":"us","size":13279}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2020-01-08 00:00","pubTimestamp":1578412800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8954970","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020000011-TRPX","pdf_url":null,"pub_time":1577894400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020000011/0001213900-20-000011-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390020000011/f6k010220_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k010220_therapixbio.htm","type":"6-K","id":"NTFILE8vd4NtiXRK8HJqAT","market":"us","size":12261}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2020-01-02 00:00","pubTimestamp":1577894400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854045","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019025895-TRPX","pdf_url":null,"pub_time":1575993600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025895/0001213900-19-025895-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"NOTICE OF ANNUAL AND SPECIAL GENERAL MEETING OF SHAREHOLDERS, PROXY STATEMENT AN","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025895/f6k121019ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k121019ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILE6BGdYjtixum6y1Ex","market":"us","size":920684},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025895/f6k121019_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k121019_therapixbio.htm","type":"6-K","id":"NTFILE7RBvUDtwVY83ZN7B","market":"us","size":17745},{"description":"VOTING INSTRUCTION FORM FOR HOLDERS OF AMERICAN DEPOSITARY SHARES","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025895/f6k121019ex99-2_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k121019ex99-2_therapixbio.htm","type":"EX-99.2","id":"NTFILE39tktsndyzrKTekb","market":"us","size":1756},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025895/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEB4kcux6uphPfYbb9","market":"us","size":12451},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025895/ex99-2_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-2_001.jpg","type":"GRAPHIC","id":"NTFILE6cXBybCXQtTk2XST","market":"us","size":1324127},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025895/ex99-2_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-2_002.jpg","type":"GRAPHIC","id":"NTFILE3vZ49EUuFPqgYs8T","market":"us","size":2872385}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2019-12-11 00:00","pubTimestamp":1575993600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854049","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019025279-TRPX","pdf_url":null,"pub_time":1575388800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/0001213900-19-025279-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"OPINION OF HORN & CO. LAW OFFICES.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/f6k120319ex5-1_therapix.htm","primary":true,"translateUrl":null,"linkName":"f6k120319ex5-1_therapix.htm","type":"EX-5.1","id":"NTFILE4sm9kfwBgdc9Tuak","market":"us","size":12322},{"description":"CURRENT REPORT OF FOREIGN ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/f6k120319_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k120319_therapixbio.htm","type":"6-K","id":"NTFILEGzQhYwag3hbrVDkn","market":"us","size":16896},{"description":"FORM OF SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE PURCHASERS IN","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/f6k120319ex10-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k120319ex10-1_therapix.htm","type":"EX-10.1","id":"NTFILE55EbpY9RYNciaMP1","market":"us","size":176707},{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON DECEMBER 4, 2019, TITLED \"T","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/f6k120319ex99-1_therapix.htm","primary":false,"translateUrl":null,"linkName":"f6k120319ex99-1_therapix.htm","type":"EX-99.1","id":"NTFILE7LEp3iKieCJ8P3CF","market":"us","size":8188},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE9zPZM7eFSh44xGGB","market":"us","size":29043},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE3wvt6zuJbxgb8Mi2","market":"us","size":5909},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025279/image_002.jpg","primary":false,"translateUrl":null,"linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILEGgU8XxHMg87hodML","market":"us","size":11861}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2019-12-04 00:00","pubTimestamp":1575388800,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854177","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019025163-TRPX","pdf_url":null,"pub_time":1575302400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025163/0001213900-19-025163-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON DECEMBER 2, 2019, TITLED TH","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025163/f6k120219ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k120219ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEAZWAyExRhGaZSLei","market":"us","size":8965},{"description":"FORM 6-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025163/f6k120219_therapixbio.htm","primary":false,"translateUrl":null,"linkName":"f6k120219_therapixbio.htm","type":"6-K","id":"NTFILE3S23EmVuRpmRh6mm","market":"us","size":11525},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019025163/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEGbkkR8f475rS3Dns","market":"us","size":11678}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2019-12-03 00:00","pubTimestamp":1575302400,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"8854048","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390019024728-TRPX","pdf_url":null,"pub_time":1574697600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Report of foreign issuer [Rules 13a-16 and 15d-16]","symbol":"TRPX","title":"Report of foreign issuer [Rules 13a-16 and 15d-16]","titleType":"Report of foreign issuer","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019024728/0001213900-19-024728-index.htm","us_notice_code":"Form 6-K","us_title_en":"Report of foreign issuer [Rules 13a-16 and 15d-16]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON NOVEMBER 20, 2019, TITLED \"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019024728/f6k112119ex99-1_therapixbio.htm","primary":true,"translateUrl":null,"linkName":"f6k112119ex99-1_therapixbio.htm","type":"EX-99.1","id":"NTFILEC5fEkfjsc4aBX5wi","market":"us","size":6632},{"description":"REPORT OF FOREIGN PRIVATE ISSUER","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019024728/f6k112119_therapixbioscience.htm","primary":false,"translateUrl":null,"linkName":"f6k112119_therapixbioscience.htm","type":"6-K","id":"NTFILEDbAznZdHAL8YuQxa","market":"us","size":10838},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1611746/000121390019024728/ex99_01.jpg","primary":false,"translateUrl":null,"linkName":"ex99_01.jpg","type":"GRAPHIC","id":"NTFILEGAqrVHCksys8Rh98","market":"us","size":17312}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Report of foreign issuer","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Report of foreign issuer","pubTime":"2019-11-26 00:00","pubTimestamp":1574697600,"title_zh":"Report of foreign issuer [Rules 13a-16 and 15d-16","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":124,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-19","symbol":"TRPX","defaultRemindTime":1603114200000,"type":"split","dateTimestamp":1603080000000,"forFactor":10000000,"toFactor":142857,"ratio":70.00007},{"market":"US","date":"2019-05-15","symbol":"TRPX","fiscalQuarterEnding":"2018/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557892800000,"reportTimeType":"","actualEps":-0.83},{"market":"US","date":"2018-12-03","symbol":"TRPX","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1543813200000,"reportTimeType":"","actualEps":-0.5},{"market":"US","date":"2018-08-20","symbol":"TRPX","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1534737600000,"reportTimeType":"","actualEps":-0.35},{"market":"US","date":"2018-05-31","symbol":"TRPX","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1527739200000,"reportTimeType":"","actualEps":0.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRPX\",market:\"US\",delay:false,,,undefined,":{}}}